BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8993853)

  • 1. Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.
    Kaye DM; Kelly RA; Smith TW
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S136-41. PubMed ID: 8993853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.
    Kaye DM; Kelly RA; Smith TW
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S136-41. PubMed ID: 21143287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells.
    Adam RM; Roth JA; Cheng HL; Rice DC; Khoury J; Bauer SB; Peters CA; Freeman MR
    J Urol; 2003 Jun; 169(6):2388-93. PubMed ID: 12771803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 5-HT2B receptor in cardiac fibroblast contributes to cardiac hypertrophy: a new therapeutic target for heart failure?
    Shyu KG
    Circ Res; 2009 Jan; 104(1):1-3. PubMed ID: 19118279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological role of HB-EGF shedding by angiotensin II in cardiomyocytes].
    Takashima S
    Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):69-75. PubMed ID: 15277724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
    Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
    Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Hirata Y; Kanno K; Eguchi S; Kano H
    Blood Press Suppl; 1994; 5():84-8. PubMed ID: 7889209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
    Hoffmann S; Krause T; van Geel PP; Willenbrock R; Pagel I; Pinto YM; Buikema H; van Gilst WH; Lindschau C; Paul M; Inagami T; Ganten D; Urata H
    J Mol Med (Berl); 2001 Oct; 79(10):601-8. PubMed ID: 11692158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraction-induced cell wounding and release of fibroblast growth factor in heart.
    Clarke MS; Caldwell RW; Chiao H; Miyake K; McNeil PL
    Circ Res; 1995 Jun; 76(6):927-34. PubMed ID: 7538917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of myocardial hypertrophy and failure: gene expression and trophic signaling.
    Parker TG
    New Horiz; 1995 May; 3(2):288-300. PubMed ID: 7583170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding growth factors in cardiac hypertrophy.
    Liao JK
    Nat Med; 2002 Jan; 8(1):20-1. PubMed ID: 11786898
    [No Abstract]   [Full Text] [Related]  

  • 13. Trophic factors for cardiac myocytes.
    Long CS; Kariya K; Karns L; Simpson PC
    J Hypertens Suppl; 1990 Dec; 8(7):S219-24. PubMed ID: 1965655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
    Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
    Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
    Higashiyama S
    Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solving the cardiac hypertrophy riddle: The angiotensin II-mechanical stress connection.
    Zablocki D; Sadoshima J
    Circ Res; 2013 Nov; 113(11):1192-5. PubMed ID: 24201113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes.
    Flannery PJ; Spurney RF
    Nephron Exp Nephrol; 2006; 103(3):e109-18. PubMed ID: 16554661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts.
    Iwami K; Ashizawa N; Do YS; Graf K; Hsueh WA
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H2100-7. PubMed ID: 8764262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts.
    Kim NN; Villarreal FJ; Printz MP; Lee AA; Dillmann WH
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E426-37. PubMed ID: 7573419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.